Akerna Corp.
Akerna Corp. KERNW Peers
See (KERNW) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KERNW | $0.00 | +5.26% | 162320.00 | -0.00 | -$0.64 | N/A |
| VEEV | $242.81 | +0.50% | 39.57B | 56.21 | $4.32 | N/A |
| GEHC | $73.13 | +0.30% | 33.49B | 15.36 | $4.76 | +0.18% |
| GEHCV | $56.00 | -4.08% | 25.46B | N/A | N/A | +0.18% |
| DOCS | $52.56 | -10.08% | 9.96B | 52.56 | $1.00 | N/A |
| SGFY | $30.49 | +0.07% | 8.93B | 70.91 | $0.43 | N/A |
| HQY | $98.23 | +0.59% | 8.50B | 90.12 | $1.09 | N/A |
| RCM | $14.31 | N/A | 6.04B | -102.21 | -$0.14 | N/A |
| BTSGU | $85.38 | +1.74% | 4.29B | N/A | N/A | N/A |
| BTSG | $24.43 | +1.71% | 4.26B | 90.48 | $0.27 | N/A |
Stock Comparison
KERNW vs VEEV Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, VEEV has a market cap of 39.57B. Regarding current trading prices, KERNW is priced at $0.00, while VEEV trades at $242.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas VEEV's P/E ratio is 56.21. In terms of profitability, KERNW's ROE is -2.22%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, KERNW is more volatile compared to VEEV. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs GEHC Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, GEHC has a market cap of 33.49B. Regarding current trading prices, KERNW is priced at $0.00, while GEHC trades at $73.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas GEHC's P/E ratio is 15.36. In terms of profitability, KERNW's ROE is -2.22%, compared to GEHC's ROE of +0.26%. Regarding short-term risk, KERNW is more volatile compared to GEHC. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs GEHCV Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, GEHCV has a market cap of 25.46B. Regarding current trading prices, KERNW is priced at $0.00, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas GEHCV's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to GEHCV's ROE of +0.26%. Regarding short-term risk, KERNW is more volatile compared to GEHCV. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs DOCS Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, DOCS has a market cap of 9.96B. Regarding current trading prices, KERNW is priced at $0.00, while DOCS trades at $52.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas DOCS's P/E ratio is 52.56. In terms of profitability, KERNW's ROE is -2.22%, compared to DOCS's ROE of +0.22%. Regarding short-term risk, KERNW is more volatile compared to DOCS. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SGFY Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SGFY has a market cap of 8.93B. Regarding current trading prices, KERNW is priced at $0.00, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SGFY's P/E ratio is 70.91. In terms of profitability, KERNW's ROE is -2.22%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, KERNW is more volatile compared to SGFY. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs HQY Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, HQY has a market cap of 8.50B. Regarding current trading prices, KERNW is priced at $0.00, while HQY trades at $98.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas HQY's P/E ratio is 90.12. In terms of profitability, KERNW's ROE is -2.22%, compared to HQY's ROE of +0.05%. Regarding short-term risk, KERNW is more volatile compared to HQY. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs RCM Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, RCM has a market cap of 6.04B. Regarding current trading prices, KERNW is priced at $0.00, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas RCM's P/E ratio is -102.21. In terms of profitability, KERNW's ROE is -2.22%, compared to RCM's ROE of -0.02%. Regarding short-term risk, KERNW is more volatile compared to RCM. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs BTSGU Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, BTSGU has a market cap of 4.29B. Regarding current trading prices, KERNW is priced at $0.00, while BTSGU trades at $85.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas BTSGU's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to BTSGU's ROE of +0.03%. Regarding short-term risk, KERNW is more volatile compared to BTSGU. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs BTSG Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, BTSG has a market cap of 4.26B. Regarding current trading prices, KERNW is priced at $0.00, while BTSG trades at $24.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas BTSG's P/E ratio is 90.48. In terms of profitability, KERNW's ROE is -2.22%, compared to BTSG's ROE of +0.03%. Regarding short-term risk, KERNW is more volatile compared to BTSG. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs ONEM Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, ONEM has a market cap of 3.40B. Regarding current trading prices, KERNW is priced at $0.00, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ONEM's P/E ratio is -7.77. In terms of profitability, KERNW's ROE is -2.22%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, KERNW is more volatile compared to ONEM. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs PRVA Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, PRVA has a market cap of 3.05B. Regarding current trading prices, KERNW is priced at $0.00, while PRVA trades at $25.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas PRVA's P/E ratio is 208.50. In terms of profitability, KERNW's ROE is -2.22%, compared to PRVA's ROE of +0.02%. Regarding short-term risk, KERNW is more volatile compared to PRVA. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs WGS Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, WGS has a market cap of 1.95B. Regarding current trading prices, KERNW is priced at $0.00, while WGS trades at $68.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas WGS's P/E ratio is -49.14. In terms of profitability, KERNW's ROE is -2.22%, compared to WGS's ROE of -0.17%. Regarding short-term risk, KERNW is more volatile compared to WGS. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs CERT Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, CERT has a market cap of 1.93B. Regarding current trading prices, KERNW is priced at $0.00, while CERT trades at $11.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CERT's P/E ratio is -594.00. In terms of profitability, KERNW's ROE is -2.22%, compared to CERT's ROE of -0.00%. Regarding short-term risk, KERNW is more volatile compared to CERT. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs PGNY Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, PGNY has a market cap of 1.91B. Regarding current trading prices, KERNW is priced at $0.00, while PGNY trades at $22.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas PGNY's P/E ratio is 39.12. In terms of profitability, KERNW's ROE is -2.22%, compared to PGNY's ROE of +0.12%. Regarding short-term risk, KERNW is more volatile compared to PGNY. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs PINC Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, PINC has a market cap of 1.90B. Regarding current trading prices, KERNW is priced at $0.00, while PINC trades at $23.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas PINC's P/E ratio is 22.67. In terms of profitability, KERNW's ROE is -2.22%, compared to PINC's ROE of +0.03%. Regarding short-term risk, KERNW is more volatile compared to PINC. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SDGR Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SDGR has a market cap of 1.73B. Regarding current trading prices, KERNW is priced at $0.00, while SDGR trades at $23.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SDGR's P/E ratio is -8.97. In terms of profitability, KERNW's ROE is -2.22%, compared to SDGR's ROE of -0.45%. Regarding short-term risk, KERNW is more volatile compared to SDGR. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs NXGN Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, NXGN has a market cap of 1.61B. Regarding current trading prices, KERNW is priced at $0.00, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas NXGN's P/E ratio is -266.00. In terms of profitability, KERNW's ROE is -2.22%, compared to NXGN's ROE of +0.03%. Regarding short-term risk, KERNW is more volatile compared to NXGN. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs PHR Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, PHR has a market cap of 1.49B. Regarding current trading prices, KERNW is priced at $0.00, while PHR trades at $25.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas PHR's P/E ratio is -24.90. In terms of profitability, KERNW's ROE is -2.22%, compared to PHR's ROE of -0.23%. Regarding short-term risk, KERNW is more volatile compared to PHR. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs GDRX Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, GDRX has a market cap of 1.41B. Regarding current trading prices, KERNW is priced at $0.00, while GDRX trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas GDRX's P/E ratio is 56.57. In terms of profitability, KERNW's ROE is -2.22%, compared to GDRX's ROE of +0.07%. Regarding short-term risk, KERNW is more volatile compared to GDRX. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs AGTI Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, AGTI has a market cap of 1.37B. Regarding current trading prices, KERNW is priced at $0.00, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas AGTI's P/E ratio is -71.79. In terms of profitability, KERNW's ROE is -2.22%, compared to AGTI's ROE of -0.03%. Regarding short-term risk, KERNW is more volatile compared to AGTI. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs TDOC Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, TDOC has a market cap of 1.32B. Regarding current trading prices, KERNW is priced at $0.00, while TDOC trades at $7.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas TDOC's P/E ratio is -1.27. In terms of profitability, KERNW's ROE is -2.22%, compared to TDOC's ROE of -0.68%. Regarding short-term risk, KERNW is more volatile compared to TDOC. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs OMCL Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, OMCL has a market cap of 1.31B. Regarding current trading prices, KERNW is priced at $0.00, while OMCL trades at $27.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas OMCL's P/E ratio is 60.78. In terms of profitability, KERNW's ROE is -2.22%, compared to OMCL's ROE of +0.02%. Regarding short-term risk, KERNW is more volatile compared to OMCL. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs TXG Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, TXG has a market cap of 1.17B. Regarding current trading prices, KERNW is priced at $0.00, while TXG trades at $9.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas TXG's P/E ratio is -7.22. In terms of profitability, KERNW's ROE is -2.22%, compared to TXG's ROE of -0.22%. Regarding short-term risk, KERNW is more volatile compared to TXG. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs EVH Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, EVH has a market cap of 1.04B. Regarding current trading prices, KERNW is priced at $0.00, while EVH trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas EVH's P/E ratio is -7.17. In terms of profitability, KERNW's ROE is -2.22%, compared to EVH's ROE of -0.11%. Regarding short-term risk, KERNW is more volatile compared to EVH. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs NUTX Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, NUTX has a market cap of 972.38M. Regarding current trading prices, KERNW is priced at $0.00, while NUTX trades at $174.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas NUTX's P/E ratio is 18.01. In terms of profitability, KERNW's ROE is -2.22%, compared to NUTX's ROE of +0.71%. Regarding short-term risk, KERNW is more volatile compared to NUTX. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs HSTM Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, HSTM has a market cap of 869.67M. Regarding current trading prices, KERNW is priced at $0.00, while HSTM trades at $28.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas HSTM's P/E ratio is 45.22. In terms of profitability, KERNW's ROE is -2.22%, compared to HSTM's ROE of +0.05%. Regarding short-term risk, KERNW is more volatile compared to HSTM. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SLP Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SLP has a market cap of 647.57M. Regarding current trading prices, KERNW is priced at $0.00, while SLP trades at $32.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SLP's P/E ratio is 89.44. In terms of profitability, KERNW's ROE is -2.22%, compared to SLP's ROE of +0.04%. Regarding short-term risk, KERNW is more volatile compared to SLP. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs MPLN-WT Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, MPLN-WT has a market cap of 625.23M. Regarding current trading prices, KERNW is priced at $0.00, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to MPLN-WT's ROE of -5.18%. Regarding short-term risk, KERNW is less volatile compared to MPLN-WT. This indicates potentially lower risk in terms of short-term price fluctuations for KERNW.
KERNW vs ACCD Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, ACCD has a market cap of 575.59M. Regarding current trading prices, KERNW is priced at $0.00, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ACCD's P/E ratio is -3.08. In terms of profitability, KERNW's ROE is -2.22%, compared to ACCD's ROE of -0.45%. Regarding short-term risk, KERNW is more volatile compared to ACCD. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs CCLDP Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, CCLDP has a market cap of 566.58M. Regarding current trading prices, KERNW is priced at $0.00, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CCLDP's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to CCLDP's ROE of +0.21%. Regarding short-term risk, KERNW is more volatile compared to CCLDP. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SHCR Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SHCR has a market cap of 531.78M. Regarding current trading prices, KERNW is priced at $0.00, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SHCR's P/E ratio is -3.76. In terms of profitability, KERNW's ROE is -2.22%, compared to SHCR's ROE of -0.29%. Regarding short-term risk, KERNW is more volatile compared to SHCR. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs CTEV Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, CTEV has a market cap of 450.19M. Regarding current trading prices, KERNW is priced at $0.00, while CTEV trades at $27.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CTEV's P/E ratio is -0.38. In terms of profitability, KERNW's ROE is -2.22%, compared to CTEV's ROE of -5.18%. Regarding short-term risk, KERNW is more volatile compared to CTEV. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SLGC Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SLGC has a market cap of 396.23M. Regarding current trading prices, KERNW is priced at $0.00, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SLGC's P/E ratio is -3.04. In terms of profitability, KERNW's ROE is -2.22%, compared to SLGC's ROE of -0.09%. Regarding short-term risk, KERNW is more volatile compared to SLGC. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SLGCW Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SLGCW has a market cap of 396.23M. Regarding current trading prices, KERNW is priced at $0.00, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, KERNW's ROE is -2.22%, compared to SLGCW's ROE of -0.09%. Regarding short-term risk, KERNW is more volatile compared to SLGCW. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs TBRG Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, TBRG has a market cap of 376.19M. Regarding current trading prices, KERNW is priced at $0.00, while TBRG trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas TBRG's P/E ratio is -20.52. In terms of profitability, KERNW's ROE is -2.22%, compared to TBRG's ROE of -0.10%. Regarding short-term risk, KERNW is more volatile compared to TBRG. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs MPLN Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, MPLN has a market cap of 374.98M. Regarding current trading prices, KERNW is priced at $0.00, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MPLN's P/E ratio is -0.23. In terms of profitability, KERNW's ROE is -2.22%, compared to MPLN's ROE of -5.18%. Regarding short-term risk, KERNW is more volatile compared to MPLN. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs DH Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, DH has a market cap of 352.08M. Regarding current trading prices, KERNW is priced at $0.00, while DH trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas DH's P/E ratio is -0.74. In terms of profitability, KERNW's ROE is -2.22%, compared to DH's ROE of -1.07%. Regarding short-term risk, KERNW is more volatile compared to DH. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SPOK Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SPOK has a market cap of 348.49M. Regarding current trading prices, KERNW is priced at $0.00, while SPOK trades at $16.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SPOK's P/E ratio is 22.00. In terms of profitability, KERNW's ROE is -2.22%, compared to SPOK's ROE of +0.10%. Regarding short-term risk, KERNW is more volatile compared to SPOK. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs NRC Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, NRC has a market cap of 319.91M. Regarding current trading prices, KERNW is priced at $0.00, while NRC trades at $14.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas NRC's P/E ratio is 13.76. In terms of profitability, KERNW's ROE is -2.22%, compared to NRC's ROE of +0.71%. Regarding short-term risk, KERNW is more volatile compared to NRC. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs TRHC Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, TRHC has a market cap of 284.03M. Regarding current trading prices, KERNW is priced at $0.00, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas TRHC's P/E ratio is -4.27. In terms of profitability, KERNW's ROE is -2.22%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, KERNW is more volatile compared to TRHC. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs HCAT Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, HCAT has a market cap of 282.58M. Regarding current trading prices, KERNW is priced at $0.00, while HCAT trades at $4.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas HCAT's P/E ratio is -3.53. In terms of profitability, KERNW's ROE is -2.22%, compared to HCAT's ROE of -0.20%. Regarding short-term risk, KERNW is more volatile compared to HCAT. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SMFR Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SMFR has a market cap of 246.37M. Regarding current trading prices, KERNW is priced at $0.00, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SMFR's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to SMFR's ROE of -0.17%. Regarding short-term risk, KERNW is more volatile compared to SMFR. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs OPRX Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, OPRX has a market cap of 211.40M. Regarding current trading prices, KERNW is priced at $0.00, while OPRX trades at $11.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas OPRX's P/E ratio is -13.61. In terms of profitability, KERNW's ROE is -2.22%, compared to OPRX's ROE of -0.13%. Regarding short-term risk, KERNW is more volatile compared to OPRX. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SOPH Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SOPH has a market cap of 197.82M. Regarding current trading prices, KERNW is priced at $0.00, while SOPH trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SOPH's P/E ratio is -2.96. In terms of profitability, KERNW's ROE is -2.22%, compared to SOPH's ROE of -0.63%. Regarding short-term risk, KERNW is more volatile compared to SOPH. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs EUDA Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, EUDA has a market cap of 141.94M. Regarding current trading prices, KERNW is priced at $0.00, while EUDA trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas EUDA's P/E ratio is -6.16. In terms of profitability, KERNW's ROE is -2.22%, compared to EUDA's ROE of +3.05%. Regarding short-term risk, KERNW is more volatile compared to EUDA. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs CPSI Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, CPSI has a market cap of 133.71M. Regarding current trading prices, KERNW is priced at $0.00, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CPSI's P/E ratio is -183.80. In terms of profitability, KERNW's ROE is -2.22%, compared to CPSI's ROE of -0.18%. Regarding short-term risk, KERNW is more volatile compared to CPSI. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs AMWL Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, AMWL has a market cap of 118.10M. Regarding current trading prices, KERNW is priced at $0.00, while AMWL trades at $7.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas AMWL's P/E ratio is -0.74. In terms of profitability, KERNW's ROE is -2.22%, compared to AMWL's ROE of -0.48%. Regarding short-term risk, KERNW is more volatile compared to AMWL. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs AUGX Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, AUGX has a market cap of 115.91M. Regarding current trading prices, KERNW is priced at $0.00, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas AUGX's P/E ratio is -4.99. In terms of profitability, KERNW's ROE is -2.22%, compared to AUGX's ROE of -1.82%. Regarding short-term risk, KERNW is more volatile compared to AUGX. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SY Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SY has a market cap of 107.40M. Regarding current trading prices, KERNW is priced at $0.00, while SY trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SY's P/E ratio is -1.04. In terms of profitability, KERNW's ROE is -2.22%, compared to SY's ROE of -0.26%. Regarding short-term risk, KERNW is more volatile compared to SY. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs CCLD Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, CCLD has a market cap of 88.87M. Regarding current trading prices, KERNW is priced at $0.00, while CCLD trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CCLD's P/E ratio is -9.55. In terms of profitability, KERNW's ROE is -2.22%, compared to CCLD's ROE of +0.21%. Regarding short-term risk, KERNW is more volatile compared to CCLD. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs CCLDO Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, CCLDO has a market cap of 85.58M. Regarding current trading prices, KERNW is priced at $0.00, while CCLDO trades at $19.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CCLDO's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to CCLDO's ROE of +0.21%. Regarding short-term risk, KERNW is more volatile compared to CCLDO. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs FORA Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, FORA has a market cap of 67.07M. Regarding current trading prices, KERNW is priced at $0.00, while FORA trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas FORA's P/E ratio is -17.92. In terms of profitability, KERNW's ROE is -2.22%, compared to FORA's ROE of -0.13%. Regarding short-term risk, KERNW is more volatile compared to FORA. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs BEATW Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, BEATW has a market cap of 54.09M. Regarding current trading prices, KERNW is priced at $0.00, while BEATW trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas BEATW's P/E ratio is -1.15. In terms of profitability, KERNW's ROE is -2.22%, compared to BEATW's ROE of -3.58%. Regarding short-term risk, KERNW is more volatile compared to BEATW. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs BEAT Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, BEAT has a market cap of 52.40M. Regarding current trading prices, KERNW is priced at $0.00, while BEAT trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas BEAT's P/E ratio is -2.12. In terms of profitability, KERNW's ROE is -2.22%, compared to BEAT's ROE of -3.58%. Regarding short-term risk, KERNW is more volatile compared to BEAT. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SHLT Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SHLT has a market cap of 41.56M. Regarding current trading prices, KERNW is priced at $0.00, while SHLT trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SHLT's P/E ratio is -4.68. In terms of profitability, KERNW's ROE is -2.22%, compared to SHLT's ROE of -0.09%. Regarding short-term risk, KERNW is more volatile compared to SHLT. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SNCE Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SNCE has a market cap of 34.66M. Regarding current trading prices, KERNW is priced at $0.00, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SNCE's P/E ratio is -0.27. In terms of profitability, KERNW's ROE is -2.22%, compared to SNCE's ROE of -0.59%. Regarding short-term risk, KERNW is more volatile compared to SNCE. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs AKLI Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, AKLI has a market cap of 34.10M. Regarding current trading prices, KERNW is priced at $0.00, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas AKLI's P/E ratio is -0.71. In terms of profitability, KERNW's ROE is -2.22%, compared to AKLI's ROE of -0.74%. Regarding short-term risk, KERNW is more volatile compared to AKLI. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SHCRW Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SHCRW has a market cap of 32.55M. Regarding current trading prices, KERNW is priced at $0.00, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, KERNW's ROE is -2.22%, compared to SHCRW's ROE of -0.29%. Regarding short-term risk, KERNW is more volatile compared to SHCRW. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs RNLX Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, RNLX has a market cap of 22.55M. Regarding current trading prices, KERNW is priced at $0.00, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas RNLX's P/E ratio is -0.33. In terms of profitability, KERNW's ROE is -2.22%, compared to RNLX's ROE of +2.93%. Regarding short-term risk, KERNW is more volatile compared to RNLX. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs LIFW Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, LIFW has a market cap of 22.36M. Regarding current trading prices, KERNW is priced at $0.00, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas LIFW's P/E ratio is -0.02. In terms of profitability, KERNW's ROE is -2.22%, compared to LIFW's ROE of -3.08%. Regarding short-term risk, KERNW is more volatile compared to LIFW. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs VSEEW Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, VSEEW has a market cap of 18.87M. Regarding current trading prices, KERNW is priced at $0.00, while VSEEW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas VSEEW's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to VSEEW's ROE of -6.10%. Regarding short-term risk, KERNW is more volatile compared to VSEEW. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs VSEE Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, VSEE has a market cap of 17.39M. Regarding current trading prices, KERNW is priced at $0.00, while VSEE trades at $1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas VSEE's P/E ratio is -13.88. In terms of profitability, KERNW's ROE is -2.22%, compared to VSEE's ROE of -6.10%. Regarding short-term risk, KERNW is more volatile compared to VSEE. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs BFRG Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, BFRG has a market cap of 16.48M. Regarding current trading prices, KERNW is priced at $0.00, while BFRG trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas BFRG's P/E ratio is -2.06. In terms of profitability, KERNW's ROE is -2.22%, compared to BFRG's ROE of -1.63%. Regarding short-term risk, KERNW is more volatile compared to BFRG. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs MSPR Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, MSPR has a market cap of 15.71M. Regarding current trading prices, KERNW is priced at $0.00, while MSPR trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MSPR's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to MSPR's ROE of -3.08%. Regarding short-term risk, KERNW is more volatile compared to MSPR. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs BBLN Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, BBLN has a market cap of 14.10M. Regarding current trading prices, KERNW is priced at $0.00, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas BBLN's P/E ratio is -0.04. In terms of profitability, KERNW's ROE is -2.22%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, KERNW is more volatile compared to BBLN. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs INOV Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, INOV has a market cap of 13.97M. Regarding current trading prices, KERNW is priced at $0.00, while INOV trades at $31.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas INOV's P/E ratio is 16.70. In terms of profitability, KERNW's ROE is -2.22%, compared to INOV's ROE of +0.03%. Regarding short-term risk, KERNW is more volatile compared to INOV. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs ONMD Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, ONMD has a market cap of 13.21M. Regarding current trading prices, KERNW is priced at $0.00, while ONMD trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ONMD's P/E ratio is -1.20. In terms of profitability, KERNW's ROE is -2.22%, compared to ONMD's ROE of +0.60%. Regarding short-term risk, KERNW is more volatile compared to ONMD. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs SCNX Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, SCNX has a market cap of 11.69M. Regarding current trading prices, KERNW is priced at $0.00, while SCNX trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas SCNX's P/E ratio is -0.17. In terms of profitability, KERNW's ROE is -2.22%, compared to SCNX's ROE of +0.19%. Regarding short-term risk, KERNW is more volatile compared to SCNX. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs ETAO Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, ETAO has a market cap of 9.78M. Regarding current trading prices, KERNW is priced at $0.00, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ETAO's P/E ratio is -0.01. In terms of profitability, KERNW's ROE is -2.22%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, KERNW is more volatile compared to ETAO. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs STRM Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, STRM has a market cap of 9.75M. Regarding current trading prices, KERNW is priced at $0.00, while STRM trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas STRM's P/E ratio is -0.89. In terms of profitability, KERNW's ROE is -2.22%, compared to STRM's ROE of -0.80%. Regarding short-term risk, KERNW is more volatile compared to STRM. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs MGRX Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, MGRX has a market cap of 9.19M. Regarding current trading prices, KERNW is priced at $0.00, while MGRX trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MGRX's P/E ratio is -0.30. In terms of profitability, KERNW's ROE is -2.22%, compared to MGRX's ROE of -0.73%. Regarding short-term risk, KERNW is more volatile compared to MGRX. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs HLTH Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, HLTH has a market cap of 6.90M. Regarding current trading prices, KERNW is priced at $0.00, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas HLTH's P/E ratio is -0.02. In terms of profitability, KERNW's ROE is -2.22%, compared to HLTH's ROE of -1.04%. Regarding short-term risk, KERNW is more volatile compared to HLTH. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs ZCMD Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, ZCMD has a market cap of 6.69M. Regarding current trading prices, KERNW is priced at $0.00, while ZCMD trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ZCMD's P/E ratio is -10.71. In terms of profitability, KERNW's ROE is -2.22%, compared to ZCMD's ROE of -0.03%. Regarding short-term risk, KERNW is more volatile compared to ZCMD. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs OTRK Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, OTRK has a market cap of 6.54M. Regarding current trading prices, KERNW is priced at $0.00, while OTRK trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas OTRK's P/E ratio is -0.09. In terms of profitability, KERNW's ROE is -2.22%, compared to OTRK's ROE of -1.76%. Regarding short-term risk, KERNW is more volatile compared to OTRK. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs EUDAW Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, EUDAW has a market cap of 5.57M. Regarding current trading prices, KERNW is priced at $0.00, while EUDAW trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas EUDAW's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to EUDAW's ROE of +3.05%. Regarding short-term risk, KERNW is more volatile compared to EUDAW. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs UPH Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, UPH has a market cap of 5.33M. Regarding current trading prices, KERNW is priced at $0.00, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas UPH's P/E ratio is -0.07. In terms of profitability, KERNW's ROE is -2.22%, compared to UPH's ROE of -1.05%. Regarding short-term risk, KERNW is more volatile compared to UPH. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs ICCT Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, ICCT has a market cap of 4.75M. Regarding current trading prices, KERNW is priced at $0.00, while ICCT trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ICCT's P/E ratio is -0.04. In terms of profitability, KERNW's ROE is -2.22%, compared to ICCT's ROE of -14.51%. Regarding short-term risk, KERNW is more volatile compared to ICCT. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs PEARW Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, PEARW has a market cap of 4.09M. Regarding current trading prices, KERNW is priced at $0.00, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas PEARW's P/E ratio is -0.00. In terms of profitability, KERNW's ROE is -2.22%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, KERNW is more volatile compared to PEARW. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs PEAR Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, PEAR has a market cap of 4.09M. Regarding current trading prices, KERNW is priced at $0.00, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas PEAR's P/E ratio is -0.08. In terms of profitability, KERNW's ROE is -2.22%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, KERNW is more volatile compared to PEAR. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs ACON Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, ACON has a market cap of 4.04M. Regarding current trading prices, KERNW is priced at $0.00, while ACON trades at $6.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ACON's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to ACON's ROE of -1.27%. Regarding short-term risk, KERNW is more volatile compared to ACON. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs FOXO Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, FOXO has a market cap of 2.46M. Regarding current trading prices, KERNW is priced at $0.00, while FOXO trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas FOXO's P/E ratio is -0.07. In terms of profitability, KERNW's ROE is -2.22%, compared to FOXO's ROE of -0.01%. Regarding short-term risk, KERNW is more volatile compared to FOXO. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs WGSWW Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, WGSWW has a market cap of 2.16M. Regarding current trading prices, KERNW is priced at $0.00, while WGSWW trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas WGSWW's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to WGSWW's ROE of -0.17%. Regarding short-term risk, KERNW is more volatile compared to WGSWW. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs CMAX Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, CMAX has a market cap of 1.61M. Regarding current trading prices, KERNW is priced at $0.00, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CMAX's P/E ratio is -0.00. In terms of profitability, KERNW's ROE is -2.22%, compared to CMAX's ROE of +30.94%. Regarding short-term risk, KERNW is more volatile compared to CMAX. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs LIFWZ Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, LIFWZ has a market cap of 1.25M. Regarding current trading prices, KERNW is priced at $0.00, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to LIFWZ's ROE of -3.08%. Regarding short-term risk, KERNW is more volatile compared to LIFWZ. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs WORX Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, WORX has a market cap of 1.17M. Regarding current trading prices, KERNW is priced at $0.00, while WORX trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas WORX's P/E ratio is -0.66. In terms of profitability, KERNW's ROE is -2.22%, compared to WORX's ROE of -0.32%. Regarding short-term risk, KERNW is more volatile compared to WORX. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs OTRKP Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, OTRKP has a market cap of 1.02M. Regarding current trading prices, KERNW is priced at $0.00, while OTRKP trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas OTRKP's P/E ratio is -0.08. In terms of profitability, KERNW's ROE is -2.22%, compared to OTRKP's ROE of -1.76%. Regarding short-term risk, KERNW is more volatile compared to OTRKP. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs HCTI Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, HCTI has a market cap of 357170.00. Regarding current trading prices, KERNW is priced at $0.00, while HCTI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas HCTI's P/E ratio is -0.01. In terms of profitability, KERNW's ROE is -2.22%, compared to HCTI's ROE of +2.95%. Regarding short-term risk, KERNW is more volatile compared to HCTI. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs KERN Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, KERN has a market cap of 162320.00. Regarding current trading prices, KERNW is priced at $0.00, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas KERN's P/E ratio is -0.01. In terms of profitability, KERNW's ROE is -2.22%, compared to KERN's ROE of -2.22%. Regarding short-term risk, KERNW is more volatile compared to KERN. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs MSPRZ Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, MSPRZ has a market cap of 82328.00. Regarding current trading prices, KERNW is priced at $0.00, while MSPRZ trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to MSPRZ's ROE of -3.08%. Regarding short-term risk, KERNW is more volatile compared to MSPRZ. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs LIFWW Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, LIFWW has a market cap of 60053.00. Regarding current trading prices, KERNW is priced at $0.00, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas LIFWW's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to LIFWW's ROE of -3.08%. Regarding short-term risk, KERNW is more volatile compared to LIFWW. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs CMAXW Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, CMAXW has a market cap of 36386.00. Regarding current trading prices, KERNW is priced at $0.00, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas CMAXW's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to CMAXW's ROE of +30.94%. Regarding short-term risk, KERNW is more volatile compared to CMAXW. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs ACONW Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, ACONW has a market cap of 21489.00. Regarding current trading prices, KERNW is priced at $0.00, while ACONW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas ACONW's P/E ratio is -0.01. In terms of profitability, KERNW's ROE is -2.22%, compared to ACONW's ROE of -1.27%. Regarding short-term risk, KERNW is more volatile compared to ACONW. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs MSPRW Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, MSPRW has a market cap of 7107.00. Regarding current trading prices, KERNW is priced at $0.00, while MSPRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas MSPRW's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to MSPRW's ROE of -3.08%. Regarding short-term risk, KERNW is more volatile compared to MSPRW. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.
KERNW vs UTRS Comparison
KERNW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KERNW stands at 162320.00. In comparison, UTRS has a market cap of 888.00. Regarding current trading prices, KERNW is priced at $0.00, while UTRS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KERNW currently has a P/E ratio of -0.00, whereas UTRS's P/E ratio is N/A. In terms of profitability, KERNW's ROE is -2.22%, compared to UTRS's ROE of -1.11%. Regarding short-term risk, KERNW is more volatile compared to UTRS. This indicates potentially higher risk in terms of short-term price fluctuations for KERNW.